Sunday, June 13, 2021
Home People on the Move

People on the Move

Ambys Medicines Appoints Ronald Park, M.D., Chief Executive Officer

SOUTH SAN FRANCISCO, Calif.-- Ambys Medicines, a cell and gene therapy company focused on advancing novel treatments to restore and regenerate liver function, today...

Selexis Appoints Roland Hoffmann-Hecht, PhD, as Chief Business Officer

GENEVA-- Selexis SA, a JSR Life Sciences company, has named seasoned business development executive Roland Hoffmann-Hecht, PhD, as its new chief business officer. As...

Precision BioSciences Appoints Alex Kelly as Chief Financial Officer

DURHAM, N.C.-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its...

Tranquis Therapeutics Strengthens Leadership Team with Appointments of Frederic Godderis as Chief Operating Officer and Jonas Hannestad as Chief Medical Officer

SAN MATEO, Calif.-- Tranquis Therapeutics, a private immuno-neurology company developing innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases,...

John Cullivan Joins PCI Pharma Services as Chief Corporate Development Officer

PHILADELPHIA-- PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced that John Cullivan has joined the Company as...

Noveome Biotherapeutics, Inc. Announces Christopher J. P. Velis as Chief Executive Officer

PITTSBURGH-- Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has...

Worldwide Clinical Trials Announces Strategic Leadership Promotions

RESEARCH TRIANGLE PARK, N.C.-- Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO), today announced two key executive...

Veteran Technology Executive Joins Synthace to Accelerate its Mission to Revolutionize the Life Science Research Market

LONDON-- Synthace Ltd, the cloud-based software platform for automating biological R&D, today announced the appointment of Guy Levy-Yurista as Chief Executive Officer (CEO) and...

AavantiBio Rounds Out Leadership Team with Appointment of Jessie Hanrahan, Ph.D. as Chief Regulatory Officer

CAMBRIDGE, Mass.-- AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, today announced the appointment of Jessie...

Intrance Medical Systems Establishes U.S. Operations and Names Patrick Shea Chief Executive Officer

STOCKHOLM & PHILADELPHIA-- Intrance Medical Systems, Inc., a subsidiary of Sweden-based Intrance Holdings AB, today announced the company has officially established its U.S. operations...

Lunaphore Announces Appointment of Matthias Weber, Former President of Leica Biosystems, to Board of Directors

AUSANNE, Switzerland-- Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research, announces the appointment of Matthias Weber, former President...

IQHQ Demonstrates its Commitment to Sustainable Development with Strategic Hire

SAN DIEGO-- IQHQ, Inc., a premier life sciences real estate development company, today announced that Jenny Whitson has joined the company in its newly-created...
- Advertisment -

Most Read